PubRank

P K Singal

Author PubWeight™ 92.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol 1982 1.87
2 The role of oxidative stress in the genesis of heart disease. Cardiovasc Res 1998 1.85
3 Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996 1.57
4 Activation of apoptotic processes during transition from hypertrophy to heart failure in guinea pigs. Am J Physiol Heart Circ Physiol 2007 1.52
5 Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997 1.50
6 Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 1996 1.50
7 Free radicals and the heart. J Pharmacol Toxicol Methods 1993 1.27
8 Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol 1994 1.26
9 Calcium movements in relation to heart function. Basic Res Cardiol 1982 1.26
10 Apoptosis in adriamycin cardiomyopathy and its modulation by probucol. Antioxid Redox Signal 2001 1.19
11 Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 1994 1.16
12 Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol 1983 1.15
13 Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radic Biol Med 1999 1.14
14 Oxidative stress and heart failure. Mol Cell Biochem 1996 1.12
15 Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis. Am J Pathol 1995 1.11
16 Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol 2000 1.09
17 Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 1995 1.07
18 Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals. Am J Physiol 1991 1.07
19 Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction. Mol Cell Biochem 2003 1.06
20 Correlation between antioxidant changes during hypoxia and recovery on reoxygenation. Am J Physiol 1991 1.03
21 Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep 1998 1.02
22 Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol. Circulation 2000 1.02
23 Metallothioneins, oxidative stress and the cardiovascular system. Toxicology 2000 1.01
24 Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy. Am J Physiol Heart Circ Physiol 2005 0.99
25 Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathy. Basic Res Cardiol 1983 0.98
26 Lipid lowering: an important factor in preventing adriamycin-induced heart failure. Am J Pathol 1997 0.95
27 Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy. Can J Cardiol 1985 0.94
28 Increase in endogenous antioxidant enzymes protects hearts against reperfusion injury. Am J Physiol 1993 0.92
29 Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes 1988 0.92
30 Direct effects of adriamycin on the rat heart sarcolemma. Res Commun Chem Pathol Pharmacol 1984 0.92
31 An ultrastructural study of the first cleavage of Xenopus embryos. J Ultrastruct Res 1974 0.92
32 Takayasu arteritis may be underdiagnosed in North America. Can J Cardiol 1995 0.90
33 Time course of structure, function, and metabolic changes due to an exogenous source of oxygen metabolites in rat heart. Can J Physiol Pharmacol 1989 0.90
34 Higher antioxidative capacity during a chronic stable heart hypertrophy. Circ Res 1989 0.90
35 Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats. Cardiovasc Res 2000 0.89
36 Calcium-related changes in the ultrastructure of mammalian myocardium. Br J Exp Pathol 1979 0.88
37 Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats. Am J Physiol 1991 0.87
38 Regional differences in non-enzymatic antioxidants in the heart under control and oxidative stress conditions. J Mol Cell Cardiol 1999 0.86
39 Mobilization of antioxidant vitamin pools and hemodynamic function after myocardial infarction. Circulation 1999 0.86
40 Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy. Mol Cell Biochem 1997 0.86
41 Influence of reducing agents on adrenochrome-induced changes in the heart. Arch Pathol Lab Med 1981 0.86
42 Protective effect of zinc against catecholamine-induced myocardial changes electrocardiographic and ultrastructural studies. Lab Invest 1981 0.86
43 Myocardial oxidative stress changes during compensated right heart failure in rats. Mol Cell Biochem 1999 0.86
44 Alterations in heart membrane calcium transport during the development of ischemia-reperfusion injury. J Mol Cell Cardiol 1988 0.85
45 Cytokines are not upregulated in adriamycin-induced cardiomyopathy and heart failure. J Mol Cell Cardiol 2004 0.84
46 Cytomembranes in first cleavage Xenopus embryos. Interrelationship between Golgi bodies, endoplasmic reticulum and lipid droplets. Cell Tissue Res 1974 0.84
47 Role of Na+-Ca2+ exchange in the development of cardiac abnormalities due to calcium paradox. Eur Heart J 1983 0.84
48 Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation. Anticancer Res 2008 0.84
49 Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stress. Mol Cell Biochem 1998 0.83
50 Cholangiocarcinoma and liver cirrhosis in relation to changes due to thioacetamide. Mol Cell Biochem 2000 0.83
51 The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyroidism. J Mol Endocrinol 2008 0.83
52 Refractory heart failure and age-related differences in adriamycin-induced myocardial changes in rats. Can J Physiol Pharmacol 1987 0.83
53 Adriamycin stimulates low-affinity Ca2+ binding and lipid peroxidation but depresses myocardial function. Am J Physiol 1986 0.83
54 Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats. J Am Coll Cardiol 2001 0.82
55 Ca2+- and Mg2+-dependent ATPase activities in the deoxycholate-treated rat heart sarcolemma. Int J Biochem 1982 0.82
56 Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol 2006 0.81
57 Antioxidant changes in heart hypertrophy: significance during hypoxia-reoxygenation injury. Can J Physiol Pharmacol 1992 0.81
58 Circaannual changes in antioxidants and oxidative stress in the heart and liver in rats. Comp Biochem Physiol C Toxicol Pharmacol 2000 0.81
59 Negatively charged sites and calcium binding in the isolated rat heart sarcolemma. Basic Res Cardiol 1981 0.81
60 Protective effect of sulfinpyrazone against catecholamine metabolite adrenochrome-induced arrhythmias. Am Heart J 1981 0.81
61 Myocardial cell damage and cardiovascular changes due to i.v. infusion of adrenochrome in rats. Br J Exp Pathol 1982 0.81
62 Metabolism of vitamin A in the heart increases after a myocardial infarction. Free Radic Biol Med 1999 0.80
63 Effects of lanthanum on the heart sarcolemmal ATPase and calcium binding activities. Can J Physiol Pharmacol 1979 0.80
64 Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy. Nutrition 1996 0.80
65 Modification of adrenochrome-induced cardiac contractile failure and cell damage by changes in cation concentrations. Lab Invest 1980 0.80
66 Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury. J Mol Cell Cardiol 1997 0.80
67 Effects of methionine on endogenous antioxidants in the heart. Am J Physiol 1999 0.80
68 Myocardial heterogeneity and regional variations in response to injury. Lab Invest 1992 0.80
69 Changes in antioxidant enzymes in isolated cardiac myocytes subjected to hypoxia-reoxygenation. Lab Invest 1992 0.80
70 Subcellular distribution of cardiac 5'-nucleotidase: alteration of microsomal pool in hypertrophied pig heart. J Mol Cell Cardiol 1986 0.80
71 Cytochemical and immunocytochemical localization of Na,K-ATPase alpha subunit isoenzymes in the rat heart. Mol Cell Biochem 1997 0.79
72 Progress and problems in understanding the involvement of calcium in heart function. Can J Physiol Pharmacol 1984 0.79
73 Effect of adrenochrome on adenine nucleotides and mitochondrial oxidative phosphorylation in rat heart. Can J Cardiol 1986 0.79
74 Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy. Mol Cell Biochem 1999 0.79
75 Time-course of cardiac myocyte injury due to oxidative stress. Mol Cell Biochem 1992 0.78
76 Effects of afterload-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats. J Am Coll Cardiol 1997 0.78
77 Occurrence of intramitochondrial Ca2+ granules in a hypertrophied heart exposed to adriamycin. Can J Physiol Pharmacol 1984 0.78
78 Protection against adrenochrome-induced myocardial damage by various pharmacological interventions. Br J Exp Pathol 1980 0.78
79 Subcellular changes during cardiac hypertrophy and heart failure due to bacterial endocarditis. Basic Res Cardiol 1980 0.78
80 Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts. Can J Cardiol 1996 0.78
81 Mode of formation of giant cells in testicular hyperthermia. Fertil Steril 1971 0.78
82 Structure-function relationship in heart sarcolemma. Adv Myocardiol 1980 0.77
83 Sarcoplasmic reticular Ca2+-pump adaptation in cardiac hypertrophy due to pressure overload in pigs. Eur Heart J 1984 0.77
84 Endogenous antioxidants in isolated hypertrophied cardiac myocytes and hypoxia-reoxygenation injury. J Mol Cell Cardiol 1995 0.77
85 Alterations in heart sarcolemmal Ca2(+)-ATPase and Ca2(+)-binding activities due to oxygen free radicals. Basic Res Cardiol 1990 0.77
86 Adriamycin does have a potentially depressant effect on left ventricular contractility. Int J Cardiol 1985 0.77
87 Cardiac cell damage: a primary myocardial disease in streptozotocin-induced chronic diabetes. Br J Exp Pathol 1984 0.77
88 Antioxidant protection against adrenaline-induced arrhythmias in rats with chronic heart hypertrophy. Can J Cardiol 1990 0.77
89 Reversibility of ultrastructural, contractile function and Ca2+ transport changes in guinea pig hearts after global ischemia. Can J Physiol Pharmacol 1986 0.77
90 Propranolol effects on myocardial ultrastructure and high energy phosphates in anesthetized dogs subjected to ischemia and reperfusion. Can J Physiol Pharmacol 1979 0.77
91 Influence of ouabain on the force-frequency relationship in cardiac muscle. Jpn Heart J 1979 0.77
92 Extracellular calcium and positive inotropy of ionophore (X537-A) in cardiac muscle. Jpn J Physiol 1976 0.77
93 Effects of ouabain on calcium paradox in rat hearts. Can J Physiol Pharmacol 1986 0.76
94 Furrow formation in Xenopus embryos. Involvement of the golgi body as revealed by ultrastructural localization of thiamine pyrophosphatase activity. Exp Cell Res 1975 0.76
95 Subcellular Ca2+ transport in different areas of dog heart. Can J Physiol Pharmacol 1980 0.76
96 Pressure overload-induced cardiac hypertrophy with and without dilation. J Am Coll Cardiol 1992 0.76
97 Preconditioning and antioxidant defense against reperfusion injury. Ann N Y Acad Sci 1994 0.76
98 Adriamycin depresses in vivo and in vitro phosphatidylethanolamine N-methylation in rat heart sarcolemma. Mol Cell Biochem 1997 0.76
99 Differences in sarcolemmal preparations: cell surface material and membrane sidedness. Basic Res Cardiol 1983 0.75
100 Ultrastructure of failing myocardium due to induced chronic mitral insufficiency in dogs. Br J Exp Pathol 1977 0.75
101 A biphasic change in contractile proteins during the development of cardiac hypertrophy in pigs. Basic Res Cardiol 1987 0.75
102 Significance of adaptation mechanisms in adriamycin induced congestive heart failure. Basic Res Cardiol 1993 0.75
103 Chromatographic analysis of protein hydrolysates of rat testis after heat shocks. Fertil Steril 1972 0.75
104 Calcium paradox. Dependence of reperfusion-induced changes on the extracellular calcium concentration. Adv Myocardiol 1980 0.75
105 Arterio-venous difference in lactate levels in myocardial ischemia and reperfusion. Can J Physiol Pharmacol 1978 0.75
106 Contracture and cell damage in calcium paradox is not caused by lipid peroxidation. Can J Physiol Pharmacol 1988 0.75
107 Transferrin delays oxygen radical induced cardiac-contractile failure. Can J Physiol Pharmacol 1990 0.75
108 Myocardial oxidative stress and antioxidants in hypertension as a result of nitric oxide synthase inhibition. Cardiovasc Toxicol 2001 0.75
109 Frequency-dependent changes in the electromechanical and (Na+, K+)-ATPase activity of cardiac muscle. Recent Adv Stud Cardiac Struct Metab 1978 0.75
110 On the role of coenzyme Q10 in cardiovascular diseases. Cardiovasc Res 1999 0.75
111 Reduced vulnerability of the hypertrophied rat heart to oxygen-radical injury. Can J Physiol Pharmacol 1987 0.75
112 Possible mechanism for the frequency-dependent increases in the cardiac contraction in monkey. Can J Physiol Pharmacol 1977 0.75
113 Subcellular changes in rat hearts perfused with potassium-free medium. Am J Physiol 1979 0.75
114 Effects of increase in extracellular calcium on frequency-dependent inotropism in cardiac muscle. Can J Cardiol 1985 0.75
115 Complete stunning in hypertrophied guinea pig heart. Defects in sarcolemmal calcium influx. Ann N Y Acad Sci 1996 0.75
116 Contractile failure and recovery in rat hearts perfused with Na+- or K+-free medium. Can J Physiol Pharmacol 1980 0.75
117 An easy method for detection of rheumatic antigen(s) in rheumatic fever/rheumatic heart disease patients by dot-ELISA. Can J Cardiol 1998 0.75
118 Oxygen radical injury in the presence of desferal, a specific iron-chelating agent. Biochem Pharmacol 1987 0.75
119 Types and distribution of lamellar bodies in first cleavage Xenopus embryos. Cell Tissue Res 1975 0.75
120 Cardiac intracellular and blood electrolytes in chronic mitral insufficiency. J Physiol (Paris) 1978 0.75
121 Unilateral hyperthermic shocks to rat testis. J Reprod Fertil 1971 0.75
122 Subcellular calcium transport during contractile failure and recovery in heart perfused with Na-free medium. Can J Physiol Pharmacol 1980 0.75
123 Testicular hyperthermic shocks and the boundary tissue of the seminiferous tubules in rats. J Reprod Fertil 1974 0.75